Enable your JavaScript to use Numstock


Numstock » ADAP

ADAP Stock Analysis

The latest metrics for Adaptimmune Therapeutics plc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -0.83
Price / Book Value Ratio < 1.5 0.57
Price / Sales Ratio < 2.0 44.44
PEG Ratio < 1.0 0.11
EV / EBITDA Ratio < 8.0 -0.09
Price / FCF Ratio Last Year < 15.0 -0.9
Price / FCF Ratio Last Quarter < 15.0 -2.08
Price / TBV Ratio Last Year < 0.7 0.32
Price / TBV Ratio Last Quarter < 0.7 0.58
Price / NCAV Ratio Last Year < 0.7 0.39
Price / NCAV Ratio Last Quarter < 0.7 0.97

Efficiency

Metric Target Value
ROE Last Year > 25.0% -42.46
ROE Last Quarter > 25.0% -23.49
ROA Last Year > 15.0% -34.51
ROA Last Quarter > 15.0% -18.87
ROTA Last Year > 20.0% -39.55
ROTA Last Quarter > 20.0% -19.27
ROIC Last Year > 20.0% -36.45
ROIC Last Quarter > 20.0% -29.27
ROCE Last Year > 20.0% -32.65
ROCE Last Quarter > 20.0% -21.83
Inventory Turnover Last Year > 4.0 90.4
Inventory Turnover Last Quarter > 4.0 19.46
Pre-tax Margin Last Year > 20.0% -203.2
Pre-tax Margin Last Quarter > 20.0% -20991
Accounts Payable Turnover Last Year > 3.0 24.07
Accounts Payable Turnover Last Quarter > 3.0 5.35
Accounts Receivable Turnover Last Year > 5.0 5.41
Accounts Receivable Turnover Last Quarter > 5.0 1.63

Health

Metric Target Value
Current Ratio Last Year > 1.5 9.46
Current Ratio Last Quarter > 1.5 6.01
Quick Ratio Last Year > 1.5 9.41
Quick Ratio Last Quarter > 1.5 5.95
Flow Ratio Last Year < 1.25 6.66
Flow Ratio Last Quarter < 1.25 4.4
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 0.0
Interest Coverage Ratio Last Quarter > 8.0 0.0
FCF / Sales Ratio Last Year > 8.0% -182
FCF / Sales Ratio Last Quarter > 8.0% -12587

Growth

Metric Target Value
Earnings Yield > 12% -120.9
Ebit Yield Last Year > 12% -182.9
Ebit Yield Last Quarter > 12% -38.32
FCF Yield Last Year > 10% -129.6
FCF Yield Last Quarter > 10% -35.7
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 1.11
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.29

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 -1.31
Altman Z-score Last Quarter ≥ 3.5 -2.55